36
A SEMINAR ON DIGOXIN , GINSENOSIDES By T. Sri Krishna

Digoxin

Embed Size (px)

Citation preview

Page 1: Digoxin

A

SEMINAR ON

DIGOXIN, GINSENOSIDES

By

T. Sri Krishna

Page 2: Digoxin

CONTENTS

History of Digoxin

Structure, Identification tests, Mechanism of action, SAR and Uses of Digoxin

History of Ginsenosides

Structure, Identification tests, Mechanism of action, SAR and Uses of Ginsenosides

Page 3: Digoxin

HISTORY OF DIGOXIN

Digoxin is used from many year ago.

William Withering(1785) -- the properties

and medicinal uses of Digital.

1799 -- direct action of digitalis on the heart.

Page 4: Digoxin

GLYCOSIDES

Glycosides – Two part the sugar(glycone)

and the aglycone.

Glycone -- non therapeutic activity and it

contains sugar moieties (ex: galacose,

mannose,arabinose).

Aglycone -- therapeutic activity.

Page 5: Digoxin

SOURCE FOR DIGOXIN

Digoxin -- Chemical

Component of Digitalis

Lanata.

Source -- Leaves

Scientific name --

Digitalis Lanata.

Common name --

Woolly foxglove , Austrial

digitalis.

Family --

Scrophulariaceae.

Page 6: Digoxin

CHEMICAL STRUCTURE

These are

composed of

two structural

features:

1) The sugar

(glycone) moiety.

2) The non-sugar

(aglycone -

steroid) moieties.

Page 7: Digoxin

R - GROUP

The R group at the 17 position difines the class of cardiac

glycoside.

Two class

1.cardenolides

2.bufadienolides

The cardenolides contains unstrutrated butyrolactone ring.

The bufadienolides contains a pyrone ring.

Page 8: Digoxin

CARDENOLIDES VS BUFADIENOLIDES

Cardenolide

It contains five

membered ring.

It is butyrolactone ring.

Bufadienolides

It contains six

membered ring.

It is a pyrone ring.

Page 9: Digoxin

STRUCTURAL FEATURES

Steroidal nucleus most be present.

3β-OH group involved in glycosidic linkage.

14β-OH group at C-14.

A/B ring junction cis

B/C ring junction trans

C/D ring junction cis

Additional OH group at C-5,C-11 and C-16 may be present.

The presence of lactone ring.

Page 10: Digoxin

IDENTIFICATION TESTS :-

General test for Steroids:

Liebermann’s test :

Glycoside in acetic anhydride+ few drop

of conc. H2SO4 Reddish violet

Green.

Page 11: Digoxin

Test For Deoxysugars:

Keller – kiliani’s Test:

Glycoside in acetic andhydride

containing of FeCl3+ conc. H2SO4 on the

wall of the tube.

Acetice acid layer acquire Bluish

–green colour (Digitalis).

Acetice acid layer acquire red

colour (Squill).

Page 12: Digoxin

Legal’s test :

Cardenolide in pryidine +Na nitroprusside

+ NaOH deep red colour .

Kedde’s test :

Cardenolide +3,5 dinitrobezoic acid

(kedde’s reagent A)+NaOH (Kedde’s reagent

B)

Violet colour .

Page 13: Digoxin

MECHANISM OF ACTION

Page 14: Digoxin

ACTION POTENTIAL

Page 15: Digoxin

Digoxin inhibits the Na-K-ATPase membrane pump, resulting in an increase in intracellular sodium.

sodium calcium exchanger (NCX)in turn tries to extrude the sodium and in so doing, pumps in more calcium.

Increased intracellular concentrations of calcium may promote activation of contractile proteins.

Page 16: Digoxin

Digoxin also acts on the electrical activity of

the heart, increasing the slope of phase 4

depolarization.

And shortening the action potential duration,

and decreasing the maximal diastolic

potential.

Page 17: Digoxin

STRUCTURE-ACTIVITY RELATIONSHIPS

Steroidal framework :-

The cis junctions between A/B and C/D rings, is

an essential request for the highest interaction

energy.

Modifying A and/or B rings related to B-C plane,

decreases the interaction energy.

The OH group at position C14 is not an

essential feature for inotropic activity, although

when it is replaced by a Hydrogen atom potency

decreases.

Page 18: Digoxin

Lactone ring :-

The presence of alpha and beta

unsaturated lactone ring increases the

activity.

If we try to saturated it losses the activity.

The lactone ring has been replaced by other

heterocycles like pyridine or piridazine rings,

energetic contribution is only partially.

Page 19: Digoxin

Sugar :-

The sugar part increases absorption and

distribution of drug in the body.

Ex:- Glucose, Rhamnose ,Cymarose,

Digitose

Page 20: Digoxin
Page 21: Digoxin

GINSENOSIDES

Page 22: Digoxin

HISTORY

Panax ginseng –5000years ago--hills of

Manchuria in China.

The word Panax, from the Greek word

meaning “all-healing”.

Widely distributed in higher plants

Toxic by i.v. injection & harmless by oral

route

Page 23: Digoxin

SOURCE OF GINSENOSIDES

Ginsenosides is

chemical component of

Panax ginseng.

Source : Main source

is root.

All parts of ginseng.

Family : Araliaceae

Page 24: Digoxin

ROOT OF GINSENG

Page 25: Digoxin

CHEMICAL STRUCTRUE

Ginsenosides are mainly divided in two types

based on chemical structure.

One is panaxadiols

And another is panaxatriols

Page 26: Digoxin

PANAXADIOLS

Page 27: Digoxin

PANAXATRIOLS

Page 28: Digoxin

STRUCTURAL FEATURES

Four trans-ring rigid steroid skeleton.

Sugar attachment at positions C-3, C-6, or C-

20.

Ring A and B ,C and D is in Cis.

It contains steroidal nucleus.

And its triterpene .

Page 29: Digoxin

CHEMICAL TEST

Test for Sugars :

Small quantity of extract was dissolved in 4 ml of distilled water and filtered and the filtrate was subjected to Molisch’s testand Iodine Test.

Test for Glycosides :

A few mg of residue was dissolved 4 ml of distilled water and filtrated and the filtrate was subjected to Legal Test and Borntrager’stest.

Page 30: Digoxin

CHEMICAL TEST

Froth test:

1 ml of aqueous solution of saponin or plant extract + shake persistent & voluminous froth.

Haemolysis test:

Suspension of RBCs in normal saline + equal volume of plant extract in normal saline + shake gently clear red solution indicating heamolysis of RBCs (compared with blank ).

Page 31: Digoxin

Test for Terpenoids :-

Knollar’s test:-

5 mg of extract is treated with 2ml of 0.1% anhydrous stannic chloride in pure thionyl chloride. A deep purple color that changes to red indicates the presence of terpenoids.

Salkowski test:-

Treat the extract with few drops of concentrated sulphuric acid ,red color at lower layer indicates presence of steroids and formation of yellow colored lower layer indicates presence of triterpenoids.

Page 32: Digoxin

STRUCTURE–ACTIVITY RELATIONSHIPS OF

GINSENOSIDES AGAINST CANCER

Number of sugar molecules :-

Anticancer activities increase with the decrease in the

number of sugar moieties.

Ginsenosides with four or more sugar molecules, such

as Rb1 and Rc, show no significant anti-proliferative

effects.

Ginsenosides Rg3 (two sugar residues), Rh2 (one

sugar residue), IH-901 (one sugar residue), PPT (no

sugar residues), and PPD (no sugar residues) inhibit

different types of cancer cells and also enhance the

efficacy of conventional chemotheraphy.

Page 33: Digoxin

With a sugar substitute at C-6, the anticancer activity of ginsenosides is decreased compared to activity with linkages at C-3 or C-20.

Dehydration at C-20 increases the bioactivity of ginsenosides .

Rg5 differs from Rg3 only by the presence of a hydroxyl group at C-20 in Rg3 and is approximately four times more effective than Rg3 at inhibiting cell proliferation .

Page 34: Digoxin

MECHANISM OF GINSENOSIDES

Ginsenosides Modulation of Immune

Function:

Different immunomodulatory effects of

ginseng have been reported, including both

immunostimulatory and immunosuppressive

effects.

Ginseng polysaccharides is used for the

Prevention and treatment of the common

cold.

Page 35: Digoxin

IMMUNOSTIMULATORY EFFECTS

enhances IL-2 interferon gamma (INF-

γ) increased proliferation of (B

lymphocytes

increased plasma level of

immunoglobulin G enhanced macrophage

production , TNF-α, IL-6 elevated the

number of spleen, bone marrow and natural

killer cells.

Page 36: Digoxin

ANTI CANCER

Cell signaling pathways involved in

apoptotic response targeted by selected

ginsenosides